Giovanni Filardo, director of epidemiology at Baylor Health Care System, and his team are executing a national multicenter study to assess the effectiveness of preventive and management strategies and their impact on incidence of post-coronary artery bypass graft surgery atrial fibrillation and long-term survival.
“Currently, we do not know what causes post-operative atrial fibrillation, nor how to identify patients at high risk and effectively prevent or mitigate this complication,” explained Filardo in a statement. “These are the questions that the study seeks to answer.”
The purpose of the long-tern study, which will finish on April 30, 2014, is to identify the causes of new-onset AF in patients undergoing cardiac surgery. Filardo said the group also hopes to discover whether or not treatment protocols for those patients who do experience the condition are effective in improving survival.
32,000 patients underwent CABG at BUMC, THHBP, Emory, University of Virginia, and Washington University between January 1997 and December 2010. Filardo said his team designed a retrospective study so they can have survival data available; otherwise it would take more than 10 years to complete the study.
For more information and a Q&A with Filardo, click here.